Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...
Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January ...
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria plus Rekambys for HIV treatment in adolescents: London, UK Saturday, February 1, 2025, 11:00 Hrs ...
Chalfont St Giles, UK Saturday, February 1, 2025, 09:00 Hrs [IST] ...
Peethaambaran Kunnathoor, Chennai Saturday, February 1, 2025, 08:00 Hrs [IST] ...
Indian healthcare sees AI and automation to bolster productivity of current workforce: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] Indian healthcare ...
DGTR initiates anti-dumping investigation into imports of MIPA from China: Shardul Nautiyal, Mumbai Saturday, February 1, 2025, 08:00 Hrs [IST] In a significant move to protect th ...
SaSPinjara Life Sciences sees Indian pharma boosting capability in high-demand therapeutics: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] SaSPinjara ...
Amount demanded by NPPA on overcharging cases declines significantly in H1 FY25: Gireesh Babu, New Delhi Saturday, February 1, 2025, 08:00 Hrs [IST] The amount demanded by the dru ...
Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...